{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:23:41Z","timestamp":1790652221675,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health, Labor, and Welfare, Japan","award":["20AA2005"],"award-info":[{"award-number":["20AA2005"]}]},{"name":"Ministry of Health, Labor, and Welfare, Japan","award":["20AA2005"],"award-info":[{"award-number":["20AA2005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00520-6","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:35:59Z","timestamp":1747208159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends and outcomes of chemotherapy timing in critically ill patients with hematologic malignancies using a Japanese national database"],"prefix":"10.1038","volume":"15","author":[{"given":"Yudai","family":"Iwasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kamio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kaiho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Ikumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuha","family":"Yabuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"520_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang, N. et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 13, 82 (2023).","journal-title":"Blood Cancer J."},{"key":"520_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jamaoncol.2016.3928","volume":"3","author":"JG Jurcic","year":"2017","unstructured":"Jurcic, J. G. Highlights in hematologic malignancy treatments: Leukemia, myelodysplastic syndromes, and allotransplant\u2014new drugs on the horizon for acute myeloid leukemia. JAMA Oncol. 3, 299\u2013300 (2017).","journal-title":"JAMA Oncol."},{"key":"520_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cell.2019.01.008","volume":"176","author":"MF Sanmamed","year":"2019","unstructured":"Sanmamed, M. F. & Chen, L. A paradigm shift in cancer immunotherapy: From enhancement to normalization. Cell 176, 677 (2019).","journal-title":"Cell"},{"key":"520_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41392-023-01521-5","volume":"8","author":"L Tang","year":"2023","unstructured":"Tang, L., Huang, Z., Mei, H. & Hu, Y. Immunotherapy in hematologic malignancies: Achievements, challenges and future prospects. Signal. Transduct. Target. Ther. 8, 306 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"520_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41408-020-0323-4","volume":"10","author":"D Pulte","year":"2020","unstructured":"Pulte, D., Jansen, L. & Brenner, H. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood Cancer J. 10, 56 (2020).","journal-title":"Blood Cancer J."},{"key":"520_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00134-021-06502-2","volume":"47","author":"BL Ferreyro","year":"2021","unstructured":"Ferreyro, B. L. et al. Critical illness in patients with hematologic malignancy: A population-based cohort study. Intensive Care Med. 47, 1104\u20131114 (2021).","journal-title":"Intensive Care Med."},{"key":"520_CR7","doi-asserted-by":"publisher","first-page":"9431385","DOI":"10.1155\/2016\/9431385","volume":"2016","author":"M Cornish","year":"2016","unstructured":"Cornish, M., Butler, M. B. & Green, R. S. Predictors of poor outcomes in critically ill adults with hematologic malignancy. Can. Respir. J. 2016, 9431385 (2016).","journal-title":"Can. Respir. J."},{"key":"520_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1179\/1607845414Y.0000000206","volume":"20","author":"M Grgi\u0107 Medi\u0107","year":"2015","unstructured":"Grgi\u0107 Medi\u0107, M., Gornik, I. & Ga\u0161parovi\u0107, V. Hematologic malignancies in the medical intensive care unit\u2014Outcomes and prognostic factors. Hematology 20, 247\u2013253 (2015).","journal-title":"Hematology"},{"key":"520_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00134-019-05918-1","volume":"46","author":"PH Asdahl","year":"2020","unstructured":"Asdahl, P. H., Christensen, S., Kj\u00e6rsgaard, A., Christiansen, C. F. & Kamper, P. One-year mortality among non-surgical patients with hematological malignancies admitted to the intensive care unit: A Danish nationwide population-based cohort study. Intensive Care Med. 46, 756\u2013765 (2020).","journal-title":"Intensive Care Med."},{"key":"520_CR10","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3109\/10428194.2015.1106537","volume":"57","author":"P Wohlfarth","year":"2016","unstructured":"Wohlfarth, P. et al. Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma. Leuk. Lymphoma 57, 1831\u20131838 (2016).","journal-title":"Leuk. Lymphoma"},{"key":"520_CR11","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1002\/cncr.31409","volume":"124","author":"SM Pastores","year":"2018","unstructured":"Pastores, S. M. et al. Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit. Cancer 124, 3025\u20133036 (2018).","journal-title":"Cancer"},{"key":"520_CR12","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00277-018-3312-y","volume":"97","author":"MG Kiehl","year":"2018","unstructured":"Kiehl, M. G. et al. Consensus statement for cancer patients requiring intensive care support. Ann. Hematol. 97, 1271\u20131282 (2018).","journal-title":"Ann. Hematol."},{"key":"520_CR13","first-page":"559","volume":"21","author":"I Moors","year":"2015","unstructured":"Moors, I., P\u00e8ne, F., Lengline, \u00c9. & Benoit, D. Urgent chemotherapy in hematological patients in the ICU. Curr. Opin. Crit. Care 21, 559\u2013568 (2015).","journal-title":"Curr. Opin. Crit. Care"},{"key":"520_CR14","doi-asserted-by":"publisher","first-page":"704318","DOI":"10.1155\/2014\/704318","volume":"2014","author":"S Malak","year":"2014","unstructured":"Malak, S. et al. Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: Guidelines of the ethics commission of the French society of hematology. Adv. Hematol. 2014, 704318 (2014).","journal-title":"Adv. Hematol."},{"key":"520_CR15","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/cc12695","volume":"17","author":"JE Zimmerman","year":"2013","unstructured":"Zimmerman, J. E., Kramer, A. A. & Knaus, W. A. Changes in hospital mortality for united States intensive care unit admissions from 1988 to 2012. Crit. Care 17, R81 (2013).","journal-title":"Crit. Care"},{"key":"520_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","volume":"49","author":"G Grasselli","year":"2023","unstructured":"Grasselli, G. et al. ESICM guidelines on acute respiratory distress syndrome: Definition, phenotyping and respiratory support strategies. Intensive Care Med. 49, 727\u2013759 (2023).","journal-title":"Intensive Care Med."},{"key":"520_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47, 1181\u20131247 (2021).","journal-title":"Intensive Care Med."},{"key":"520_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.hemonc.2018.03.003","volume":"11","author":"N Al-Zubaidi","year":"2018","unstructured":"Al-Zubaidi, N. et al. Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit. Hematol. Oncol. Stem Cell. Ther. 11, 206\u2013218 (2018).","journal-title":"Hematol. Oncol. Stem Cell. Ther."},{"key":"520_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/CCM.0000000000000852","volume":"43","author":"N Khandelwal","year":"2015","unstructured":"Khandelwal, N. et al. Estimating the effect of palliative care interventions and advance care planning on ICU utilization: A systematic review. Crit. Care Med. 43, 1102\u20131111 (2015).","journal-title":"Crit. Care Med."},{"key":"520_CR20","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/cc9975","volume":"15","author":"LT Cardoso","year":"2011","unstructured":"Cardoso, L. T. et al. Impact of delayed admission to intensive care units on mortality of critically ill patients: A cohort study. Crit. Care 15, R28 (2011).","journal-title":"Crit. Care"},{"key":"520_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13613-021-00898-2","volume":"11","author":"EN van der Zee","year":"2021","unstructured":"van der Zee, E. N. et al. Outcome of cancer patients considered for intensive care unit admission in two university hospitals in The Netherlands: The danger of delayed ICU admissions and off-hour triage decisions. Ann. Intensive Care. 11, 125 (2021).","journal-title":"Ann. Intensive Care"},{"key":"520_CR22","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00134-017-4884-z","volume":"43","author":"E Azoulay","year":"2017","unstructured":"Azoulay, E. et al. The intensive care medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med. 43, 1366\u20131382 (2017).","journal-title":"Intensive Care Med."},{"key":"520_CR23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00268-013-1926-8","volume":"37","author":"M Kastrup","year":"2013","unstructured":"Kastrup, M. et al. Catecholamine dosing and survival in adult intensive care unit patients. World J. Surg. 37, 766\u2013773 (2013).","journal-title":"World J. Surg."},{"key":"520_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2110-5820-1-5","volume":"1","author":"E Azoulay","year":"2011","unstructured":"Azoulay, E. et al. Intensive care of the cancer patient: Recent achievements and remaining challenges. Ann. Intensive Care 1, 5 (2011).","journal-title":"Ann. Intensive Care"},{"key":"520_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.zefq.2016.07.010","volume":"115\u2013116","author":"EI Benchimol","year":"2016","unstructured":"Benchimol, E. I. et al. Das RECORD-statement zum berichten von beobachtungsstudien, die Routinem\u00e4\u00dfig gesammelte gesundheitsdaten Verwenden [The REporting of studies conducted using observational routinely-collected health data (RECORD) statement]. Z. Evid. Fortbild. Qual. Gesundhwes 115\u2013116, 33\u201348 (2016).","journal-title":"Z. Evid. Fortbild. Qual. Gesundhwes"},{"key":"520_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12884-019-2352-1","volume":"19","author":"D Shigemi","year":"2019","unstructured":"Shigemi, D., Aso, S. & Yasunaga, H. Inappropriate use of ritodrine hydrochloride for threatened preterm birth in Japan: A retrospective cohort study using a national inpatient database. BMC Pregnancy Childbirth 19, 204 (2019).","journal-title":"BMC Pregnancy Childbirth"},{"key":"520_CR27","doi-asserted-by":"publisher","first-page":"19m12993","DOI":"10.4088\/JCP.19m12993","volume":"81","author":"D Shigemi","year":"2020","unstructured":"Shigemi, D., Ishimaru, M., Matsui, H., Fushimi, K. & Yasunaga, H. Suicide attempts among pregnant and postpartum women in Japan: A nationwide retrospective cohort study. J. Clin. Psychiatry. 81, 19m12993 (2020).","journal-title":"J. Clin. Psychiatry"},{"key":"520_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 40, 373\u2013383 (1987).","journal-title":"J. Chronic Dis."},{"key":"520_CR29","doi-asserted-by":"publisher","first-page":"e002736","DOI":"10.1136\/bmjopen-2013-002736","volume":"3","author":"K Shigematsu","year":"2013","unstructured":"Shigematsu, K., Nakano, H. & Watanabe, Y. The eye response test alone is sufficient to predict stroke outcome\u2013reintroduction of Japan coma scale: A cohort study. BMJ Open. 3, e002736 (2013).","journal-title":"BMJ Open."},{"key":"520_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.6004\/jnccn.2022.0002","volume":"20","author":"NS Callander","year":"2022","unstructured":"Callander, N. S. et al. NCCN guidelines\u00ae insights: Multiple myeloma, version 3.2022. J. Natl. Compr. Canc Netw. 20, 8\u201319 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"520_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","volume":"19","author":"DA Pollyea","year":"2021","unstructured":"Pollyea, D. A. et al. NCCN guidelines insights: Acute myeloid leukemia, version 2.2021. J. Natl. Compr. Cancer Netw. 19, 16\u201327 (2021).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"520_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.6004\/jnccn.2019.0024","volume":"17","author":"PA Brown","year":"2019","unstructured":"Brown, P. A. et al. Guidelines insights: Acute lymphoblastic leukemia, version 1.2019. J. Natl. Compr. Cancer Netw. 17, 414\u2013423 (2019).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"520_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.6004\/jnccn.2019.0002","volume":"17","author":"WG Wierda","year":"2019","unstructured":"Wierda, W. G. et al. NCCN guidelines insights: Chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 2.2019. J. Natl. Compr. Canc Netw. 17, 12\u201320 (2019).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"520_CR34","first-page":"97","volume":"11","author":"A Brown","year":"2019","unstructured":"Brown, A., Kumar, S. & Tchounwou, P. B. Cisplatin-based chemotherapy of human cancers. J. Cancer Sci. Ther. 11, 97 (2019).","journal-title":"J. Cancer Sci. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00520-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:35:59Z","timestamp":1747208159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00520-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00520-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"19 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16725"}}